Nutrien (NYSE:NTR) Announces Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Nutrien (NYSE:NTRGet Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.04), Briefing.com reports. The firm had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.35 EPS.

Nutrien Stock Performance

Nutrien stock opened at $48.32 on Friday. Nutrien has a fifty-two week low of $44.65 and a fifty-two week high of $60.87. The firm’s 50 day simple moving average is $47.98 and its 200-day simple moving average is $50.61. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.26 and a quick ratio of 0.82. The company has a market cap of $23.86 billion, a P/E ratio of 32.43, a price-to-earnings-growth ratio of 1.62 and a beta of 0.82.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.939 per share. The ex-dividend date is Tuesday, December 31st. This is a positive change from Nutrien’s previous quarterly dividend of $0.54. This represents a $3.76 dividend on an annualized basis and a yield of 7.77%. Nutrien’s dividend payout ratio is currently 144.97%.

Analyst Upgrades and Downgrades

NTR has been the topic of a number of research reports. Hsbc Global Res cut shares of Nutrien from a “hold” rating to a “moderate sell” rating in a report on Friday, August 2nd. HSBC downgraded shares of Nutrien from a “hold” rating to a “reduce” rating in a research report on Friday, August 2nd. The Goldman Sachs Group cut shares of Nutrien from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $69.00 to $53.00 in a research report on Tuesday, September 10th. Barclays reduced their price objective on Nutrien from $68.00 to $55.00 and set an “overweight” rating for the company in a research report on Friday, August 16th. Finally, UBS Group cut Nutrien from a “buy” rating to a “neutral” rating and lowered their target price for the company from $66.00 to $51.00 in a research report on Thursday, October 10th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $60.44.

Check Out Our Latest Stock Report on Nutrien

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

See Also

Earnings History for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.